Literature DB >> 3355618

Small polydisperse low density lipoproteins in familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activity.

S Yamashita1, Y Matsuzawa, M Okazaki, H Kako, T Yasugi, H Akioka, K Hirano, S Tarui.   

Abstract

Lipoprotein abnormalities were analyzed in 3 cases of marked hyperalphalipoproteinemia caused by complete deficiency of cholesteryl ester transfer activity. The probands were all men, aged 34, 43 and 48 years, respectively. The serum high density lipoprotein (HDL)-cholesterol levels of these patients were higher than 150 mg/dl (157-254 mg/dl), while serum total cholesterol levels ranged from 227 to 360 mg/dl. Sequential flotation-ultracentrifugation analysis disclosed that low density lipoprotein (LDL)-cholesterol was slightly decreased and that cholesteryl ester accumulated solely in the HDL2 fraction, which was also enriched with apolipoprotein E. Cholesteryl ester transfer activity was completely absent in all of these cases. High-performance liquid chromatography showed a decrease of LDL particle size in combination with a marked enlargement of HDL particle size. Analytical ultracentrifugation disclosed heterogeneity of LDL with the presence of small LDL subpopulations. We conclude that hyperalphalipoproteinemia due to complete deficiency of cholesteryl ester transfer activity is characterized by the presence of both small polydisperse LDL and markedly large HDL enriched with cholesteryl ester and apolipoprotein E.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3355618     DOI: 10.1016/0021-9150(88)90094-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  13 in total

1.  Low density lipoprotein heterogeneity in spontaneously hypercholesterolemic pigs.

Authors:  S T Cooper; R J Aiello; W J Checovich; A D Attie
Journal:  Mol Cell Biochem       Date:  1992-08-18       Impact factor: 3.396

Review 2.  Interaction of lipid transfer protein with plasma lipoproteins and cell membranes.

Authors:  R E Morton
Journal:  Experientia       Date:  1990-06-15

3.  Evacetrapib reduces preβ-1 HDL in patients with atherosclerotic cardiovascular disease or diabetes.

Authors:  Yunqin Chen; Jibin Dong; Xiaojin Zhang; Xueying Chen; Li Wang; Haozhu Chen; Junbo Ge; Xian-Cheng Jiang
Journal:  Atherosclerosis       Date:  2019-04-14       Impact factor: 5.162

4.  Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency.

Authors:  S Yamashita; D L Sprecher; N Sakai; Y Matsuzawa; S Tarui; D Y Hui
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

5.  Endotoxin and cytokines decrease serum levels and extra hepatic protein and mRNA levels of cholesteryl ester transfer protein in syrian hamsters.

Authors:  I Hardardóttir; A H Moser; J Fuller; C Fielding; K Feingold; C Grünfeld
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

6.  Lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients.

Authors:  E Manzato; A Zambon; S Zambon; R Nosadini; A Doria; R Marin; G Crepaldi
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

Review 7.  Cholesteryl ester transfer protein and its inhibitors.

Authors:  Sudichhya Shrestha; Ben J Wu; Liam Guiney; Philip J Barter; Kerry-Anne Rye
Journal:  J Lipid Res       Date:  2018-02-27       Impact factor: 5.922

8.  Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency.

Authors:  K Ikewaki; M Nishiwaki; T Sakamoto; T Ishikawa; T Fairwell; L A Zech; M Nagano; H Nakamura; H B Brewer; D J Rader
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

Review 9.  High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease.

Authors:  Navin K Kapur; Dominique Ashen; Roger S Blumenthal
Journal:  Vasc Health Risk Manag       Date:  2008

10.  Disease-associated marked hyperalphalipoproteinemia.

Authors:  Ken-Ichi Hirano; Hironori Nagasaka; Kazuhiro Kobayashi; Satoshi Yamaguchi; Akira Suzuki; Tatsushi Toda; Manabu Doyu
Journal:  Mol Genet Metab Rep       Date:  2014-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.